Painless gastroenteroscopy
Conditions
Interventions
Group C (cypofol group):After oxygen monitoring, 0.1µg/kg sufentanil was injected intravenously. One minute later, cyclopropofol 0.4mg/kg was slowly injected intravenously in group C, and the endoscop
group P (propofol group):After oxygen monitoring, 0.1µg/kg sufentanil was injected intravenously. One minute later, propofol 2mg/kg was administered slowly intravenously in group P. When BIS value was
Sponsors
Department of Anesthesiology, Honghui Hospital, Xi'an Jiaotong University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) Patients who have undergone painless gastroscopy at our hospital on a scheduled basis; (2) Age range from 18 to 65 years old; (3) ASA level I-II; (4) 18kg/m2<BMI<30kg/m2; (5) The patient or their family members sign an informed consent form.
Exclusion criteria
Exclusion criteria: (1) Patients who are allergic to the investigational drug or have other contraindications; (2) Severe diseases of the heart, brain, lungs, liver, kidneys, lungs, and endocrine system.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mean arterial pressure, heart rate, respiratory rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| The success rate of first sedation and the addition rate of sedative drugs; | — |
Countries
China
Contacts
Public ContactWang Fang
Department of Anesthesiology, Honghui Hospital, Xi'an Jiaotong University
Outcome results
None listed